SSG
HQCL

Summit Securities Group’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Summit Securities Group’s Portfolio HQCL Stock Details HQCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-230
Closed -$10K – 625
2013
Q3 		$10K Buy
+230
New +$7.59K ﹤0.01% 262

Other funds holding HQCL

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
SCM
Seamans Capital Management Boston, Massachusetts $30.2M AUM 15.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ECM
Empire Capital Management Westport, Connecticut $29.8M AUM 2.42% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Summit Securities Group's HQCL Position: Q4 2013 in Review

Summit Securities Group sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q4 2013, closing a stake of 230 shares — an estimated $10K sold.

Summit Securities Group first reported a position in HQCL in Q3 2013 and held it in 1 quarter. The position peaked at $10K in Q3 2013. 35 funds tracked by Wall St. Rank hold HQCL as of Q4 2013.

  • Summit Securities Group reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q4 2013 after selling out during the quarter.
  • Summit Securities Group sold 230 Hanwha Q CELLS Co., Ltd. shares in Q4 2013, an estimated $10K.
  • Summit Securities Group first reported a position in Hanwha Q CELLS Co., Ltd. in Q3 2013 and held it in 1 quarter.
  • Summit Securities Group's Hanwha Q CELLS Co., Ltd. position peaked at $10K in Q3 2013.
  • 35 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q4 2013.

Based on Summit Securities Group's 13F filing for Q4 2013, filed 13 Feb 2014.